Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1131, pseudogene (RNU6-1131P) is a human pseudogene, located on chromosome 18, which is annotated as a non-protein-coding gene derived from the U6 small nuclear RNA (snRNA) gene family[8]. U6 snRNA pseudogenes represent DNA sequences that are similar to the functional U6 snRNA gene but are not believed to be transcriptionally active or to encode functional RNA molecules[7][8]. Functional U6 snRNA is an essential component of the spliceosome, playing a critical role in the splicing of pre-messenger RNA (pre-mRNA)[1][3][5][9]. However, RNU6-1131P, as a pseudogene, is not expected to be transcribed into a functional RNA and does not have an established biological or disease role[8]. In general, some pseudogenes can have regulatory roles—such as serving as sources of small interfering RNAs (siRNAs) or acting as competing endogenous RNAs (ceRNAs)—but there is no evidence or literature supporting this function for RNU6-1131P specifically[4][6]. No known therapeutic agents, drug interactions, clinical biomarkers, or safety concerns are associated with RNU6-1131P. It is not considered a therapeutic target or disease biomarker. Key points: - RNU6-1131P is a pseudogene related to functional U6 snRNA, but itself lacks known function[8]. - Not considered a receptor, enzyme, transporter, or classical therapeutic target. - No known involvement in disease, biomarker use, or drug interaction for this specific pseudogene. - Its existence is typical of the U6 gene family, which has many non-functional or pseudogenic copies in the human genome[3][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1131, pseudogene (RNU6-1131P).